Nanosonics (ASX:NAN) logged AU$0.0577 in EPS for 2026, compared with AU$0.0669 a year ago, a Tuesday filing showed.
For the 12 months ended June 30, revenue was AU$203.9 million versus AU$198.6 million previously, the Australia-listed healthcare company added.
The company expects 2027 revenue in the range of AU$220 million to AU$228 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.